ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 2017–2020 of 2020 project topics
MAX Gene Variant Analysis Bioinformatics Workflow Tool
An automated bioinformatics workflow software that processes MAX gene sequencing data to identify pheochromocytoma predisposition variants with clinical interpretation algorithms. The tool generates revenue through software-as-a-service licensing to genomics laboratories and clinical diagnostic centers globally.
Genetic Basis of Rare Endocrine Tumors Click to view more details →
CDKN1B CDK4 Familial Pituitary Adenoma Predictive Testing
A commercial genetic testing and predictive analytics platform that identifies CDKN1B and CDK4 mutations in familial isolated pituitary adenoma cases for early intervention. The service captures market value through clinical testing fees, long-term patient monitoring subscriptions, and licensing to specialty endocrinology clinics.
Genetic Basis of Rare Endocrine Tumors Click to view more details →
MEN4 CDKN1A Gene Sequencing Clinical Decision Support
A comprehensive gene sequencing platform with artificial intelligence-powered clinical decision support for MEN4 syndrome detection and family risk stratification in endocrine tumor patients. The platform monetizes through per-analysis fees, institutional licensing agreements, and data-driven pharmaceutical collaborations for MEN4-targeted drug development.
Genetic Basis of Rare Endocrine Tumors Click to view more details →
PTEN Hamartoma Tumor Syndrome Predictive Risk Calculator
A digital risk assessment tool that integrates PTEN mutation status with clinical phenotyping to predict endocrine tumor development in Cowden syndrome patients using machine learning models. The calculator generates revenue through institutional subscriptions, patient-facing premium features, and integration partnerships with electronic health record systems.
Genetic Basis of Rare Endocrine Tumors Click to view more details →